Industry News
SERI Partners with Carl Zeiss Meditec to Enhance Vision Care for Singapore’s Aging Population

The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec have launched a groundbreaking co...

read more
SERI Partners with Carl Zeiss Meditec to Enhance Vision Care for Singapore’s Aging Population
November 18, 2024
Study Reveals Link Between Climate Change and Eye Conditions

A groundbreaking study from the University of Colorado Anschutz Medical Campus has identified a sign...

read more
Study Reveals Link Between Climate Change and Eye Conditions
November 18, 2024
Phase 3 Trial of Eyenovia's Pediatric Myopia Treatment Falls Short of Primary Goal

Eyenovia has announced that its Phase 3 CHAPERONE study, aimed at treating pediatric progressive myo...

read more
Phase 3 Trial of Eyenovia's Pediatric Myopia Treatment Falls Short of Primary Goal
November 18, 2024
Sun Pharma Reports Positive Phase 4 Data for Cequa in Dry Eye Disease Management

Sun Pharmaceutical has shared new Phase 4 clinical trial data, showcasing the efficacy of Cequa (cyc...

read more
Sun Pharma Reports Positive Phase 4 Data for Cequa in Dry Eye Disease Management
November 15, 2024
Australian Researchers Identify 101 Genetic Regions Linked to Cataract Risk

In the largest genetic study on cataracts to date, researchers from QIMR Berghofer Medical Research ...

read more
Australian Researchers Identify 101 Genetic Regions Linked to Cataract Risk
November 15, 2024
Bausch + Lomb Recycling Programs Collect Over 94 Million Units of Eye Care Waste in the U.S.

Through its exclusive recycling initiatives, Bausch + Lomb has collected 94,119,275 units of used co...

read more
Bausch + Lomb Recycling Programs Collect Over 94 Million Units of Eye Care Waste in the U.S.
November 15, 2024
MediPrint Ophthalmics Announces Promising Phase 2b Results for Drug-Eluting Contact Lens in Glaucoma Management

MediPrint Ophthalmics has revealed positive findings from its Phase 2b clinical trial for LL-BMT1, a...

read more
MediPrint Ophthalmics Announces Promising Phase 2b Results for Drug-Eluting Contact Lens in Glaucoma Management
November 14, 2024
Stem Cell Breakthrough Restores Human Vision in Regenerative Medicine Milestone

In a groundbreaking achievement, researchers from Osaka University in Japan have successfully conduc...

read more
Stem Cell Breakthrough Restores Human Vision in Regenerative Medicine Milestone
November 14, 2024
Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for Gene Therapy ATSN-101

Atsena Therapeutics, Inc. and Nippon Shinyaku Co., Ltd. have entered an exclusive licensing agreemen...

read more
Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for Gene Therapy ATSN-101
November 14, 2024
Oklahoma Neonatologist-Researcher Awarded $2.3 Million NIH Grant to Advance Retinopathy of Prematurity Research

Dr. Faizah Bhatti, a neonatologist and researcher from the University of Oklahoma, has been awarded ...

read more
Oklahoma Neonatologist-Researcher Awarded $2.3 Million NIH Grant to Advance Retinopathy of Prematurity Research
November 13, 2024
More